- United States
- /
- Software
- /
- NasdaqGM:BNFT
Is It Time To Consider Buying Benefitfocus, Inc. (NASDAQ:BNFT)?
Benefitfocus, Inc. (NASDAQ:BNFT), which is in the software business, and is based in United States, saw significant share price movement during recent months on the NASDAQGM, rising to highs of $41.51 and falling to the lows of $25. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Benefitfocus's current trading price of $26.38 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Benefitfocus’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
See our latest analysis for Benefitfocus
Is Benefitfocus still cheap?
Good news, investors! Benefitfocus is still a bargain right now. According to my valuation, the intrinsic value for the stock is $47.64, but it is currently trading at US$26.38 on the share market, meaning that there is still an opportunity to buy now. However, given that Benefitfocus’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
Can we expect growth from Benefitfocus?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 34% over the next couple of years, the future seems bright for Benefitfocus. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? Since BNFT is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.
Are you a potential investor? If you’ve been keeping an eye on BNFT for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy BNFT. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.
Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Benefitfocus. You can find everything you need to know about Benefitfocus in the latest infographic research report. If you are no longer interested in Benefitfocus, you can use our free platform to see my list of over 50 other stocks with a high growth potential.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
About NasdaqGM:BNFT
Benefitfocus
Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States.
Slightly overvalued with imperfect balance sheet.
Similar Companies
Market Insights
Weekly Picks

Looking to be second time lucky with a game-changing new product
PlaySide Studios: Market Is Sleeping on a Potential 10M+ Unit Breakout Year, FY26 Could Be the Rerate of the Decade

Inotiv NAMs Test Center
This isn’t speculation — this is confirmation.A Schedule 13G was filed, not a 13D, meaning this is passive institutional capital, not acti
Recently Updated Narratives

Goldman Sachs Group (GS) The Titan Reclaims Its Crown: Return to Core Excellence

Parker-Hannifin (PH) The Industrial Alchemist: Transforming Motion into Margin

Monolithic Power Systems (MPWR) Powering the Hyperscale Era: The Efficiency Moat
Popular Narratives

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

